TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 2 January 17, 2012
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 2 January 17, 2012
(The next issue will be on February 1, 2012)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/12g4pzVJvrgr5Uqj5JD6Vcp/
Benagiano M, Munari F, Ciervo A, Amedei A, Paccani SR, Mancini F, . . . D'Elios MM (2012) Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A.
http://www.ncbi.nlm.nih.gov/pubmed/22232679
Ben-Hadj-Khalifa S, Hezard N, Almawi WY, Lakbakbi S, Mace C, Cornillet-Lefebvre P, . . . Nguyen P (2011) IL-10 modulates fondaparinux inhibition of monocyte-induced thrombin generation. J Thromb Thrombolysis 32:311-317.
http://www.ncbi.nlm.nih.gov/pubmed/21725623
Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P, Schwartz J (2012) Air Pollution and Markers of Coagulation, Inflammation, and Endothelial Function: Associations and Epigene-environment Interactions in an Elderly Cohort. Epidemiology.
http://www.ncbi.nlm.nih.gov/pubmed/22237295
Chan CM, Shorr AF, Perkins JG (2012) Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: A retrospective analysis. J Crit Care.
http://www.ncbi.nlm.nih.gov/pubmed/22227085
Chen XD, Li ZW, Zhang J, Mao ZH, Ma D, Wang HJ (2012) Tissue factor pathway inhibitor-2 may interact with nuclear protein RASSF1C. Acta Biochim Biophys Sin (Shanghai).
http://www.ncbi.nlm.nih.gov/pubmed/22232300
Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebo R, Kierulf P, . . . Sandset PM (2012) A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22217510
Fang Y, Cai JY, Zhong JH, Zhong H, Wang HR, Chen FY (2011) [Expression of alternatively spliced human tissue factor in acute leukemia cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19:288-292.
http://www.ncbi.nlm.nih.gov/pubmed/21518473
Fogelson AL, Hussain YH, Leiderman K (2012) Blood Clot Formation under Flow: The Importance of Factor XI Depends Strongly on Platelet Count. Biophys J 102:10-18.
http://www.ncbi.nlm.nih.gov/pubmed/22225793
Girolami A, Bertozzi I, de Marinis GB, Bonamigo E, Fabris F (2011) Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes. Hematology 16:308-312.
http://www.ncbi.nlm.nih.gov/pubmed/21902896
Girolami A, Bertozzi I, Rigoni I, Muzzolon R, Vettore S (2011) Congenital FVII deficiency and thrombotic events after replacement therapy. J Thromb Thrombolysis 32:362-367.
http://www.ncbi.nlm.nih.gov/pubmed/21681394
Gudmundsdottir BR, Francis CW, Bjornsdottir AM, Nellbring M, Onundarson PT (2012) Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22225856
Hahn N, Heiden M, Seitz R, Salge-Bartels U (2012) Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion. J Cancer Res Clin Oncol.
http://www.ncbi.nlm.nih.gov/pubmed/22237453
Hammad MA, Abdel-Bakky MS, Walker LA, Ashfaq MK (2011) Oxidized low-density lipoprotein and tissue factor are involved in monocrotaline/lipopolysaccharide-induced hepatotoxicity. Arch Toxicol 85:1079-1089.
http://www.ncbi.nlm.nih.gov/pubmed/21279329
Ho KM, Litton E (2011) Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion. Transfusion.
http://www.ncbi.nlm.nih.gov/pubmed/22211634
Holroyd EW, Delacroix S, Larsen K, Harbuzariu A, Psaltis PJ, Wang L, . . . Simari RD (2012) Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl Terminus. Arterioscler Thromb Vasc Biol.
http://www.ncbi.nlm.nih.gov/pubmed/22223730
Holtom E, Usherwood JR, Macey MG, Lawson C (2011) Microparticle formation after co-culture of human whole blood and umbilical artery in a novel in vitro model of flow. Cytometry A.
http://www.ncbi.nlm.nih.gov/pubmed/22213485
Humphreys I, Saraiya S, Belenky W, Dworkin J (2011) Nasal packing with strips of cured pork as treatment for uncontrollable epistaxis in a patient with Glanzmann thrombasthenia. Ann Otol Rhinol Laryngol 120:732-736.
http://www.ncbi.nlm.nih.gov/pubmed/22224315
Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB (2011) Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. J Trauma 71:S435-440.
http://www.ncbi.nlm.nih.gov/pubmed/22072000
Karpf DM, Sorensen BB, Hermit MB, Holmberg HL, Tranholm M, Bysted BV, . . . Stennicke HR (2011) Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa. Thromb Res 128:191-195.
http://www.ncbi.nlm.nih.gov/pubmed/21429564
Keyl C, Uhl R, Beyersdorf F, Stampf S, Lehane C, Wiesenack C, Trenk D (2011) High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg 39:e114-121.
http://www.ncbi.nlm.nih.gov/pubmed/21295991
Krigsfeld GS, Sanzari JK, Kennedy AR (2012) The Effects of Proton Radiation on the Prothrombin and Partial Thromboplastin Times of Irradiated Ferrets. Int J Radiat Biol.
http://www.ncbi.nlm.nih.gov/pubmed/22221163
Kristensen M, Bugel S (2011) A diet rich in oat bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers. Eur J Clin Nutr 65:1053-1058.
http://www.ncbi.nlm.nih.gov/pubmed/21654701
Lecut C, Faccinetto C, Delierneux C, van Oerle R, Spronk HM, Evans RJ, . . . Oury C (2011) ATP-gated P2X(1) ion channels protect from endotoxemia by dampening neutrophil activation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22212928
Lee AI, Campigotto F, Rawn JD, Neuberg D, Kaufman RM, Berliner N (2012) Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients. Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/22224596
Lemmer R, Albrech M, Bauer G (2012) Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage. J Obstet Gynaecol Res.
http://www.ncbi.nlm.nih.gov/pubmed/22229547
Lindstrom OK, Tukiainen EM, Kylanpaa ML, Mentula PJ, Puolakkainen PA, Wartiovaara-Kautto UM, . . . Petaja JM (2011) Thrombin Generation in vitro and in vivo, and Disturbed Tissue Factor Regulation in Patients with Acute Pancreatitis. Pancreatology 11:557-566.
http://www.ncbi.nlm.nih.gov/pubmed/22213026
Maroney SA, Ellery PE, Wood JP, Ferrel JP, Bonesho CE, Mast AE (2012) Caveolae Optimize Tissue Factor-Factor VIIa Inhibitory Activity of Cell Surface Associated Tissue Factor Pathway Inhibitor. Biochem J.
http://www.ncbi.nlm.nih.gov/pubmed/22239091
Meade TW, Stirling Y (2012) The Northwick Park Heart Studies: contrasts Between the Two Factor VII Assays Used. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22235852
Mobarrez F, He S, Broijersen A, Wiklund B, Antovic A, Antovic J, . . . Wallen H (2011) Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost 106:344-352.
http://www.ncbi.nlm.nih.gov/pubmed/21614411
Moertl D, Berger R, Hammer A, Hutuleac R, Koppensteiner R, Kopp CW, Steiner S (2011) Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure. Thromb Haemost 106:457-465.
http://www.ncbi.nlm.nih.gov/pubmed/21800004
Newell-Caito JL, Laha M, Tharp AC, Creamer JI, Xu H, Maddur AA, . . . Bock PE (2011) Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes. J Biol Chem 286:38286-38297.
http://www.ncbi.nlm.nih.gov/pubmed/21911491
Ott I (2011) Inhibitors of the initiation of coagulation. Br J Clin Pharmacol 72:547-552.
http://www.ncbi.nlm.nih.gov/pubmed/21392058
Owens AP, 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, . . . Mackman N (2012) Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest.
http://www.ncbi.nlm.nih.gov/pubmed/22214850
Pepke W, Eisenreich A, Jaster M, Ayral Y, Bobbert P, Mayer A, . . . Rauch U (2011) Bivalirudin Inhibits Periprocedural Platelet Function and Tissue Factor Expression of Human Smooth Muscle Cells. Cardiovasc Ther.
http://www.ncbi.nlm.nih.gov/pubmed/22212466
Poon A, Litonjua AA, Laprise C (2011) Relevance and implication of genetic determinants to asthma pathophysiology. Curr Opin Allergy Clin Immunol 11:407-413.
http://www.ncbi.nlm.nih.gov/pubmed/21822132
Riddell A, Abdul-Kadir R, Pollard D, Tuddenham E, Gomez K (2011) Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb Haemost 106:521-527.
http://www.ncbi.nlm.nih.gov/pubmed/21833443
Schulte S (2011) Pioneering designs for recombinant coagulation factors. Thromb Res 128 Suppl 1:S9-S12.
http://www.ncbi.nlm.nih.gov/pubmed/22221848
Sie P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, . . . Albaladejo P (2011) [Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors]. Ann Fr Anesth Reanim 30:645-650.
http://www.ncbi.nlm.nih.gov/pubmed/21820844
Silverstein RL (2012) Teaching an old dog new tricks: potential antiatherothrombotic use for statins. J Clin Invest:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/22214843
Stavenuiter F, Dienava-Verdoold I, Boon-Spijker MG, Brinkman HJ, Meijer AB, Mertens K (2012) Factor Seven Activating Protease (FSAP): does it Activate Factor VII? J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22235940
Tarzia V, Bottio T, Buratto E, Spiezia L, Simioni P, Gerosa G (2011) The hazard of comparing apples and oranges: the proper indication for the use of recombinant activated clotting factor VII in cardiac surgery. J Thorac Cardiovasc Surg 142:1588-1589; author reply 1589.
http://www.ncbi.nlm.nih.gov/pubmed/22093717
Taylor KC, Lange LA, Zabaneh D, Lange E, Keating BJ, Tang W, . . . Reiner AP (2011) A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium. Hum Mol Genet 20:3525-3534.
http://www.ncbi.nlm.nih.gov/pubmed/21676895
Tersteeg C, Roest M, Mak-Nienhuis EM, Ligtenberg E, Hoefer IE, de Groot PG, Pasterkamp G (2012) A fibronectin-fibrinogen-tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell function. J Cell Mol Med.
http://www.ncbi.nlm.nih.gov/pubmed/22225866
Tong J, Che T, Li Y, Wang P, Xu X, Chen Y (2011) A descriptor of amino acids: SVRG and its application to peptide quantitative structure-activity relationship. SAR QSAR Environ Res 22:611-620.
http://www.ncbi.nlm.nih.gov/pubmed/21830880
Tsimerman G, Roguin A, Bachar A, Melamed E, Brenner B, Aharon A (2011) Involvement of microparticles in diabetic vascular complications. Thromb Haemost 106:310-321.
http://www.ncbi.nlm.nih.gov/pubmed/21713319
Viswabandya A, Baidya S, Nair SC, Abraham A, George B, Mathews V, . . . Srivastava A (2012) Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22221743
Whitehead KA, Sahay G, Li GZ, Love KT, Alabi CA, Ma M, . . . Anderson DG (2011) Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery. Mol Ther 19:1688-1694.
http://www.ncbi.nlm.nih.gov/pubmed/21750531
Zareh M, Davis A, Henderson S (2011) Reversal of warfarin-induced hemorrhage in the emergency department. West J Emerg Med 12:386-392.
http://www.ncbi.nlm.nih.gov/pubmed/22224125
Zhao B, Luo X, Shi H, Ma D (2011) Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thromb Res 128:179-185.
http://www.ncbi.nlm.nih.gov/pubmed/21458846
__________________________________________________________
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/12g4pzVJvrgr5Uqj5JD6Vcp/
Benagiano M, Munari F, Ciervo A, Amedei A, Paccani SR, Mancini F, . . . D'Elios MM (2012) Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A.
http://www.ncbi.nlm.nih.gov/pubmed/22232679
Ben-Hadj-Khalifa S, Hezard N, Almawi WY, Lakbakbi S, Mace C, Cornillet-Lefebvre P, . . . Nguyen P (2011) IL-10 modulates fondaparinux inhibition of monocyte-induced thrombin generation. J Thromb Thrombolysis 32:311-317.
http://www.ncbi.nlm.nih.gov/pubmed/21725623
Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P, Schwartz J (2012) Air Pollution and Markers of Coagulation, Inflammation, and Endothelial Function: Associations and Epigene-environment Interactions in an Elderly Cohort. Epidemiology.
http://www.ncbi.nlm.nih.gov/pubmed/22237295
Chan CM, Shorr AF, Perkins JG (2012) Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: A retrospective analysis. J Crit Care.
http://www.ncbi.nlm.nih.gov/pubmed/22227085
Chen XD, Li ZW, Zhang J, Mao ZH, Ma D, Wang HJ (2012) Tissue factor pathway inhibitor-2 may interact with nuclear protein RASSF1C. Acta Biochim Biophys Sin (Shanghai).
http://www.ncbi.nlm.nih.gov/pubmed/22232300
Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebo R, Kierulf P, . . . Sandset PM (2012) A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22217510
Fang Y, Cai JY, Zhong JH, Zhong H, Wang HR, Chen FY (2011) [Expression of alternatively spliced human tissue factor in acute leukemia cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19:288-292.
http://www.ncbi.nlm.nih.gov/pubmed/21518473
Fogelson AL, Hussain YH, Leiderman K (2012) Blood Clot Formation under Flow: The Importance of Factor XI Depends Strongly on Platelet Count. Biophys J 102:10-18.
http://www.ncbi.nlm.nih.gov/pubmed/22225793
Girolami A, Bertozzi I, de Marinis GB, Bonamigo E, Fabris F (2011) Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes. Hematology 16:308-312.
http://www.ncbi.nlm.nih.gov/pubmed/21902896
Girolami A, Bertozzi I, Rigoni I, Muzzolon R, Vettore S (2011) Congenital FVII deficiency and thrombotic events after replacement therapy. J Thromb Thrombolysis 32:362-367.
http://www.ncbi.nlm.nih.gov/pubmed/21681394
Gudmundsdottir BR, Francis CW, Bjornsdottir AM, Nellbring M, Onundarson PT (2012) Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22225856
Hahn N, Heiden M, Seitz R, Salge-Bartels U (2012) Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion. J Cancer Res Clin Oncol.
http://www.ncbi.nlm.nih.gov/pubmed/22237453
Hammad MA, Abdel-Bakky MS, Walker LA, Ashfaq MK (2011) Oxidized low-density lipoprotein and tissue factor are involved in monocrotaline/lipopolysaccharide-induced hepatotoxicity. Arch Toxicol 85:1079-1089.
http://www.ncbi.nlm.nih.gov/pubmed/21279329
Ho KM, Litton E (2011) Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion. Transfusion.
http://www.ncbi.nlm.nih.gov/pubmed/22211634
Holroyd EW, Delacroix S, Larsen K, Harbuzariu A, Psaltis PJ, Wang L, . . . Simari RD (2012) Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl Terminus. Arterioscler Thromb Vasc Biol.
http://www.ncbi.nlm.nih.gov/pubmed/22223730
Holtom E, Usherwood JR, Macey MG, Lawson C (2011) Microparticle formation after co-culture of human whole blood and umbilical artery in a novel in vitro model of flow. Cytometry A.
http://www.ncbi.nlm.nih.gov/pubmed/22213485
Humphreys I, Saraiya S, Belenky W, Dworkin J (2011) Nasal packing with strips of cured pork as treatment for uncontrollable epistaxis in a patient with Glanzmann thrombasthenia. Ann Otol Rhinol Laryngol 120:732-736.
http://www.ncbi.nlm.nih.gov/pubmed/22224315
Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB (2011) Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. J Trauma 71:S435-440.
http://www.ncbi.nlm.nih.gov/pubmed/22072000
Karpf DM, Sorensen BB, Hermit MB, Holmberg HL, Tranholm M, Bysted BV, . . . Stennicke HR (2011) Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa. Thromb Res 128:191-195.
http://www.ncbi.nlm.nih.gov/pubmed/21429564
Keyl C, Uhl R, Beyersdorf F, Stampf S, Lehane C, Wiesenack C, Trenk D (2011) High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg 39:e114-121.
http://www.ncbi.nlm.nih.gov/pubmed/21295991
Krigsfeld GS, Sanzari JK, Kennedy AR (2012) The Effects of Proton Radiation on the Prothrombin and Partial Thromboplastin Times of Irradiated Ferrets. Int J Radiat Biol.
http://www.ncbi.nlm.nih.gov/pubmed/22221163
Kristensen M, Bugel S (2011) A diet rich in oat bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers. Eur J Clin Nutr 65:1053-1058.
http://www.ncbi.nlm.nih.gov/pubmed/21654701
Lecut C, Faccinetto C, Delierneux C, van Oerle R, Spronk HM, Evans RJ, . . . Oury C (2011) ATP-gated P2X(1) ion channels protect from endotoxemia by dampening neutrophil activation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22212928
Lee AI, Campigotto F, Rawn JD, Neuberg D, Kaufman RM, Berliner N (2012) Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients. Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/22224596
Lemmer R, Albrech M, Bauer G (2012) Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage. J Obstet Gynaecol Res.
http://www.ncbi.nlm.nih.gov/pubmed/22229547
Lindstrom OK, Tukiainen EM, Kylanpaa ML, Mentula PJ, Puolakkainen PA, Wartiovaara-Kautto UM, . . . Petaja JM (2011) Thrombin Generation in vitro and in vivo, and Disturbed Tissue Factor Regulation in Patients with Acute Pancreatitis. Pancreatology 11:557-566.
http://www.ncbi.nlm.nih.gov/pubmed/22213026
Maroney SA, Ellery PE, Wood JP, Ferrel JP, Bonesho CE, Mast AE (2012) Caveolae Optimize Tissue Factor-Factor VIIa Inhibitory Activity of Cell Surface Associated Tissue Factor Pathway Inhibitor. Biochem J.
http://www.ncbi.nlm.nih.gov/pubmed/22239091
Meade TW, Stirling Y (2012) The Northwick Park Heart Studies: contrasts Between the Two Factor VII Assays Used. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22235852
Mobarrez F, He S, Broijersen A, Wiklund B, Antovic A, Antovic J, . . . Wallen H (2011) Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost 106:344-352.
http://www.ncbi.nlm.nih.gov/pubmed/21614411
Moertl D, Berger R, Hammer A, Hutuleac R, Koppensteiner R, Kopp CW, Steiner S (2011) Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure. Thromb Haemost 106:457-465.
http://www.ncbi.nlm.nih.gov/pubmed/21800004
Newell-Caito JL, Laha M, Tharp AC, Creamer JI, Xu H, Maddur AA, . . . Bock PE (2011) Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes. J Biol Chem 286:38286-38297.
http://www.ncbi.nlm.nih.gov/pubmed/21911491
Ott I (2011) Inhibitors of the initiation of coagulation. Br J Clin Pharmacol 72:547-552.
http://www.ncbi.nlm.nih.gov/pubmed/21392058
Owens AP, 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, . . . Mackman N (2012) Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest.
http://www.ncbi.nlm.nih.gov/pubmed/22214850
Pepke W, Eisenreich A, Jaster M, Ayral Y, Bobbert P, Mayer A, . . . Rauch U (2011) Bivalirudin Inhibits Periprocedural Platelet Function and Tissue Factor Expression of Human Smooth Muscle Cells. Cardiovasc Ther.
http://www.ncbi.nlm.nih.gov/pubmed/22212466
Poon A, Litonjua AA, Laprise C (2011) Relevance and implication of genetic determinants to asthma pathophysiology. Curr Opin Allergy Clin Immunol 11:407-413.
http://www.ncbi.nlm.nih.gov/pubmed/21822132
Riddell A, Abdul-Kadir R, Pollard D, Tuddenham E, Gomez K (2011) Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb Haemost 106:521-527.
http://www.ncbi.nlm.nih.gov/pubmed/21833443
Schulte S (2011) Pioneering designs for recombinant coagulation factors. Thromb Res 128 Suppl 1:S9-S12.
http://www.ncbi.nlm.nih.gov/pubmed/22221848
Sie P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, . . . Albaladejo P (2011) [Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors]. Ann Fr Anesth Reanim 30:645-650.
http://www.ncbi.nlm.nih.gov/pubmed/21820844
Silverstein RL (2012) Teaching an old dog new tricks: potential antiatherothrombotic use for statins. J Clin Invest:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/22214843
Stavenuiter F, Dienava-Verdoold I, Boon-Spijker MG, Brinkman HJ, Meijer AB, Mertens K (2012) Factor Seven Activating Protease (FSAP): does it Activate Factor VII? J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22235940
Tarzia V, Bottio T, Buratto E, Spiezia L, Simioni P, Gerosa G (2011) The hazard of comparing apples and oranges: the proper indication for the use of recombinant activated clotting factor VII in cardiac surgery. J Thorac Cardiovasc Surg 142:1588-1589; author reply 1589.
http://www.ncbi.nlm.nih.gov/pubmed/22093717
Taylor KC, Lange LA, Zabaneh D, Lange E, Keating BJ, Tang W, . . . Reiner AP (2011) A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium. Hum Mol Genet 20:3525-3534.
http://www.ncbi.nlm.nih.gov/pubmed/21676895
Tersteeg C, Roest M, Mak-Nienhuis EM, Ligtenberg E, Hoefer IE, de Groot PG, Pasterkamp G (2012) A fibronectin-fibrinogen-tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell function. J Cell Mol Med.
http://www.ncbi.nlm.nih.gov/pubmed/22225866
Tong J, Che T, Li Y, Wang P, Xu X, Chen Y (2011) A descriptor of amino acids: SVRG and its application to peptide quantitative structure-activity relationship. SAR QSAR Environ Res 22:611-620.
http://www.ncbi.nlm.nih.gov/pubmed/21830880
Tsimerman G, Roguin A, Bachar A, Melamed E, Brenner B, Aharon A (2011) Involvement of microparticles in diabetic vascular complications. Thromb Haemost 106:310-321.
http://www.ncbi.nlm.nih.gov/pubmed/21713319
Viswabandya A, Baidya S, Nair SC, Abraham A, George B, Mathews V, . . . Srivastava A (2012) Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22221743
Whitehead KA, Sahay G, Li GZ, Love KT, Alabi CA, Ma M, . . . Anderson DG (2011) Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery. Mol Ther 19:1688-1694.
http://www.ncbi.nlm.nih.gov/pubmed/21750531
Zareh M, Davis A, Henderson S (2011) Reversal of warfarin-induced hemorrhage in the emergency department. West J Emerg Med 12:386-392.
http://www.ncbi.nlm.nih.gov/pubmed/22224125
Zhao B, Luo X, Shi H, Ma D (2011) Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thromb Res 128:179-185.
http://www.ncbi.nlm.nih.gov/pubmed/21458846
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
